CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
CH Koh, S Lee, M Kwak, BS Kim… - Experimental & Molecular …, 2023 - nature.com
CD8 T cells play crucial roles in immune surveillance and defense against infections and
cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire …
cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire …
IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?
Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative
immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid …
immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid …
Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade
Y Zhang, RN Sriramaneni, PA Clark… - Nature …, 2022 - nature.com
Radiation therapy (RT) activates an in situ vaccine effect when combined with immune
checkpoint blockade (ICB), yet this effect may be limited because RT does not fully optimize …
checkpoint blockade (ICB), yet this effect may be limited because RT does not fully optimize …
Research progress on tumor hypoxia-associative nanomedicine
XX Xu, SY Chen, NB Yi, X Li, SL Chen, Z Lei… - Journal of Controlled …, 2022 - Elsevier
Hypoxia at the solid tumor site is generally related to the unrestricted proliferation and
metabolism of cancerous cells, which can cause tumor metastasis and aggravate tumor …
metabolism of cancerous cells, which can cause tumor metastasis and aggravate tumor …
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
J Li, Z Xiao, D Wang, L Jia, S Nie, X Zeng, W Hu - Molecular Cancer, 2023 - Springer
Recent advances in neoantigen research have accelerated the development of tumor
immunotherapies, including adoptive cell therapies (ACTs), cancer vaccines and antibody …
immunotherapies, including adoptive cell therapies (ACTs), cancer vaccines and antibody …
Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with advanced-stage ERBB2-positive breast cancer: a phase 1 …
MLN Disis, KA Guthrie, Y Liu, AL Coveler… - JAMA …, 2023 - jamanetwork.com
Importance High levels of ERBB2 (formerly HER2)–specific type 1 T cells in the peripheral
blood are associated with favorable clinical outcomes after trastuzumab therapy; however …
blood are associated with favorable clinical outcomes after trastuzumab therapy; however …
Peripheral blood-based biomarkers for immune checkpoint inhibitors
As cancer immunotherapy using immune checkpoint inhibitors (ICIs) is rapidly evolving in
clinical practice, it is necessary to identify biomarkers that will allow the selection of cancer …
clinical practice, it is necessary to identify biomarkers that will allow the selection of cancer …
CD8+ T cell metabolic rewiring defined by scRNA-seq identifies a critical role of ASNS expression dynamics in T cell differentiation
J Fernandez-Garcia, F Franco, S Parik… - Cell Reports, 2022 - cell.com
T cells dynamically rewire their metabolism during an immune response. We applied single-
cell RNA sequencing to CD8+ T cells activated and differentiated in vitro in physiological …
cell RNA sequencing to CD8+ T cells activated and differentiated in vitro in physiological …
pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer
SW Zhu, M Ye, X Ma, ZZ Wu, SC Wan, SC Yang, H Li… - Acta Biomaterialia, 2022 - Elsevier
As the prominent feature of the development and progression of head and neck squamous
cell carcinoma (HNSCC) is immunosuppression, therapeutic strategies to restore antitumor …
cell carcinoma (HNSCC) is immunosuppression, therapeutic strategies to restore antitumor …
Harnessing engineered immune cells and bacteria as drug carriers for cancer immunotherapy
Immunotherapy continues to be in the spotlight of oncology therapy research in the past few
years and has been proven to be a promising option to modulate one's innate and adaptive …
years and has been proven to be a promising option to modulate one's innate and adaptive …